Physician

Andrew Chung Yang, M.D.

According to 2025 Medicare claims, Andrew Yang, M.D. (NPI: 1316232168) practices hematology/oncology in the Everett, WA market, with the plurality of this provider's patient population coming from Snohomish, WA. This provider's primary affiliated billing organization is OPTUM CARE WASHINGTON PLLC (NPI: 1831186766; TIN: 910214500) and primary practice location at 98201-1621. Yang is affiliated with the PSW ACO (ACO ID: A5323) and CareMount Value Partners IPA (ACO ID: D0019), participating under both the MSSP and REACH models.

Yang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 453 traditional Medicare patients, billed 95,508 HCPCS/CPT codes, and received $1,839,633 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,234 prescription claims across 370 beneficiaries totaling $6,201,627 in drug costs, led by Erleada (Apalutamide). 2023 DME data shows 74 claims. Open Payments data shows 3 records totaling $20,178. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,454 to $6,201,627. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	176	22,592	$360,646
2020	367	64,730	$1,269,037
2021	388	66,896	$1,362,933
2022	331	68,732	$1,242,020
2023	401	82,626	$1,181,107
2024	453	95,508	$1,839,633

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	13	20	$2,454
2016	36	88	$14,510
2017	50	207	$59,554
2018	29	133	$60,671
2019	57	164	$90,141
2020	171	1,045	$1,591,662
2021	168	1,255	$1,949,668
2022	210	1,415	$2,646,506
2023	247	1,676	$3,230,234
2024	370	2,234	$6,201,627

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	122	$7,379
2021	N/R	95	$5,130
2022	N/R	91	$4,707
2023	N/R	74	$2,200
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	146	266	$134
96413	Administration of chemotherapy into vein, 1 hour or less	94	249	$104
80053	Blood test, comprehensive group of blood chemicals	148	567	$10
36415	Insertion of needle into vein for collection of blood sample	166	708	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	158	741	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erleada	Apalutamide	87	2,670	$1,405,493
Xtandi	Enzalutamide	55	1,650	$769,053
Lenalidomide	Lenalidomide	51	1,421	$767,553
Pomalyst	Pomalidomide	28	784	$657,736
Ibrance	Palbociclib	25	700	$428,235

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$150	ADC Therapeutics America, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$20,028	Merck Sharp & Dohme LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrew Chung Yang, M.D.?

Tedicare shows public-source Medicare data for Andrew Chung Yang, M.D. (NPI 1316232168), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Chung Yang, M.D. have ACO affiliation data?

Andrew Chung Yang, M.D. is shown with ACO affiliation data for PSW ACO (MSSP, ACO ID A5323) and CareMount Value Partners IPA (REACH, ACO ID D0019).

What billing organization is linked to Andrew Chung Yang, M.D.?

Andrew Chung Yang, M.D. is linked to OPTUM CARE WASHINGTON PLLC (billing NPI 1831186766) in the available physician profile data.

Does Andrew Chung Yang, M.D. have Open Payments data?

Andrew Chung Yang, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.